PT-141 (Bremelanotide) — Melanocortin Research Peptide

Description
PT-141, also known as Bremelanotide, is a synthetic peptide studied for its interaction with melanocortin receptors, particularly within central nervous system pathways. In laboratory environments, it is utilized in research exploring receptor-mediated signaling related to neuroendocrine and behavioral response systems.

Unlike compounds that act through vascular pathways, PT-141 is primarily examined for its activity at melanocortin receptor subtypes (such as MC3R and MC4R), making it a valuable tool in studies focused on central signaling mechanisms and peptide–receptor interactions.

Its distinct mechanism has made PT-141 a compound of interest in controlled research models investigating neuropeptide signaling and regulatory pathways.

Key Research Areas

• Melanocortin receptor interaction (MC3R, MC4R)
• Central nervous system signaling pathways
• Neuropeptide and receptor-mediated responses
• Neuroendocrine system regulation
• Behavioral and signaling pathway studies

Specifications

Compound: PT-141 (Bremelanotide)
Peptide Class: Melanocortin receptor agonist
Purity: ≥98% (HPLC)
Appearance: Lyophilized powder

Important Notice

This product is intended strictly for laboratory research purposes only.
Not for human consumption, medical use, or diagnostic applications.
Handling should be performed by qualified professionals in appropriate research environments.